{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T04:19:05Z","timestamp":1774585145881,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012127","name":"Augusta University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012127","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009670","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.schres.2019.10.062","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T10:37:27Z","timestamp":1575283047000},"page":"41-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Meta-analysis of comorbid diabetes and family history of diabetes in non-affective psychosis"],"prefix":"10.1016","volume":"216","author":[{"given":"Jim","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2019.10.062_bib1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4239\/wjd.v4.i4.114","article-title":"Genetics of DM2","volume":"4","author":"Ali","year":"2013","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.schres.2019.10.062_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029228","article-title":"Association of the DM2 mellitus susceptibility gene, TCF7L2, with schizophrenia in an Arab-Israeli family sample","volume":"7","author":"Alkelai","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2019.10.062_bib3","author":"American Diabetes Association"},{"key":"10.1016\/j.schres.2019.10.062_bib4","author":"Annis"},{"key":"10.1016\/j.schres.2019.10.062_bib5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.cca.2012.03.021","article-title":"Interleukin-1 (IL-1) family of cytokines: role in DM2","volume":"413","author":"Banerjee","year":"2012","journal-title":"Clinica. Chimica. Acta."},{"issue":"11","key":"10.1016\/j.schres.2019.10.062_bib6","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1176\/appi.ajp.2011.11010048","article-title":"Diagnostic shifts during the decade following first admission for psychosis","volume":"168","author":"Bromet","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2019.10.062_bib7","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1176\/appi.ajp.159.7.1080","article-title":"Obstetric complications and schizophrenia: historical and meta-analytic review","volume":"159","author":"Cannon","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2019.10.062_bib62","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/biomet\/37.3-4.256","article-title":"The comparison of percentages in matched samples","volume":"37","author":"Cochran","year":"1950","journal-title":"Biometrika"},{"issue":"6","key":"10.1016\/j.schres.2019.10.062_bib9","doi-asserted-by":"crossref","first-page":"e746","DOI":"10.4088\/JCP.15r10373","article-title":"Efficacy for psychopathology and body weight and safety of topiramate-antipsychotic contreatment in patients with schizophrenia spectrum disorders: results from a meta-analysis of randomized controlled trials","volume":"77","author":"Correll","year":"2016","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.schres.2019.10.062_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/archpsyc.56.3.234","article-title":"Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort","volume":"56","author":"Dalman","year":"1999","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.schres.2019.10.062_bib11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.nmd.0000180737.85895.60","article-title":"Physical activity patterns in adults with severe mental illness","volume":"193","author":"Daumit","year":"2005","journal-title":"J.\u00a0Nerv. Ment. Dis."},{"issue":"3","key":"10.1016\/j.schres.2019.10.062_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials. Control","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Clin. Trials"},{"key":"10.1016\/j.schres.2019.10.062_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12888-016-1049-5","article-title":"Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis","volume":"16","author":"de Silva","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2019.10.062_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1176\/appi.psy.49.2.123","article-title":"Evidence of exacerbated cognitive deficits in schizophrenia patients with comorbid diabetes","volume":"49","author":"Dickinson","year":"2008","journal-title":"Psychosomatics"},{"key":"10.1016\/j.schres.2019.10.062_bib67","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Br. Med. J."},{"key":"10.1016\/j.schres.2019.10.062_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.apnu.2006.10.004","article-title":"Doing my best: poverty and self-care among individuals with schizophrenia and diabetes mellitus","volume":"21","author":"El-Mallakh","year":"2007","journal-title":"Arch. Psychiatr. Nurs."},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.10.062_bib16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.schres.2007.10.002","article-title":"Parental history of type 2 diabetes in patients with nonaffective psychosis","volume":"179","author":"Fernandez-Egea","year":"2008","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.10.062_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.schres.2008.04.017","article-title":"Glucose abnormalities in the siblings of people with schizophrenia","volume":"103","author":"Fernandez-Egea","year":"2008","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2019.10.062_bib18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/wps.20130","article-title":"Predictors of type 2 diabetes in a nationally representative sample of adults with psychosis","volume":"13","author":"Foley","year":"2014","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2019.10.062_bib19","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S2215-0366(15)00276-X","article-title":"Effect of age, family history of diabetes, and antipsychotic drug treatment on risk of diabetes in people with psychosis: a population-based cross-sectional study","volume":"2","author":"Foley","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2019.10.062_bib20","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.amjmed.2006.02.031","article-title":"Metabolic syndrome and risk of cardiovascular disease: a meta-analysis","volume":"119","author":"Galassi","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.schres.2019.10.062_bib71","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00210-013-0933-5","article-title":"Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects","volume":"387","author":"Girault","year":"2014","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"suppl","key":"10.1016\/j.schres.2019.10.062_bib72","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0269881105058380","article-title":"Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?","volume":"19","author":"Gough","year":"2005","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.schres.2019.10.062_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.schres.2016.09.026","article-title":"Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-na\u00efve patients with nonaffective psychosis","volume":"179","author":"Greenhalgh","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.10.062_bib22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S2215-0366(15)00115-7","article-title":"Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses","volume":"2","author":"Henderson","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2019.10.062_bib23","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","article-title":"Schizophrenia and increased risks of cardiovascular disease","volume":"150","author":"Hennekens","year":"2005","journal-title":"Am. Heart J."},{"key":"10.1016\/j.schres.2019.10.062_bib90","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. 9.7. Sensitivity Analyses","author":"Higgins","year":"2011"},{"key":"10.1016\/j.schres.2019.10.062_bib24","first-page":"1","article-title":"Increased risk of type 2 diabetes among the siblings of patients with schizophrenia","volume":"3","author":"Huang","year":"2019","journal-title":"CNS Spectr."},{"issue":"7","key":"10.1016\/j.schres.2019.10.062_bib25","first-page":"1202","article-title":"Diabetes mellitus in patients with schizophrenia in taiwan","volume":"34","author":"Hung","year":"2005","journal-title":"Prog. NeuroPsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2019.10.062_bib61","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/1468-2389.00156","article-title":"Fixed Effects vs. Random Effects meta-analysis models: implications for cumulative research knowledge","volume":"8","author":"Hunter","year":"2000","journal-title":"Int. J. Sel. Assess."},{"key":"10.1016\/j.schres.2019.10.062_bib26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00125-012-2715-x","article-title":"The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study","volume":"56","author":"InterAct Consortium","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.schres.2019.10.062_bib27","first-page":"197","article-title":"Shared early life risk factors for schizophrenia and diabetes","volume":"54","author":"Kandhal","year":"2013","journal-title":"Minerva Psichiatr."},{"key":"10.1016\/j.schres.2019.10.062_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1192\/bjp.184.47.s64","article-title":"Diabetes mellitus and schizophrenia: historical perspective","volume":"184","author":"Kohen","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2019.10.062_bib30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1440-1819.2011.02218.x","article-title":"Screening for diabetes using Japanese monitoring guidance in schizophrenia patients treated with second-generation antipsychotics: a cross-sectional study using baseline data","volume":"65","author":"Kusumi","year":"2011","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.schres.2019.10.062_bib31","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4088\/JCP.v65n0517","article-title":"Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs","volume":"65","author":"Lamberti","year":"2004","journal-title":"J.\u00a0Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2019.10.062_bib32","doi-asserted-by":"crossref","first-page":"900","DOI":"10.4088\/JCP.v66n0713","article-title":"Diabetes mellitus among outpatients receiving clozapine","volume":"66","author":"Lamberti","year":"2005","journal-title":"J.\u00a0Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2019.10.062_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/0706743716644765","article-title":"Dopamine 2 receptor genes are associated with raised blood glucose in schizophrenia","volume":"61","author":"Lawford","year":"2016","journal-title":"Can. J. Psychiatr."},{"issue":"6","key":"10.1016\/j.schres.2019.10.062_bib34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s004060070005","article-title":"The genetic epidemiology of schizophrenia and of schizophrenia spectrum disorders","volume":"250","author":"Lichtermann","year":"2000","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2019.10.062_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.10.062_bib36","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archpsyc.61.10.985","article-title":"Summer birth and deficit schizophrenia: a pooled analysis from 6 countries","volume":"61","author":"Messias","year":"2004","journal-title":"Arch. Gen. Psychiatr."},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.10.062_bib37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.schres.2016.04.035","article-title":"Parental type 2 diabetes in patients with non-affective psychosis","volume":"175","author":"Miller","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.10.062_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1017\/S003329171100105X","article-title":"Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices","volume":"42","author":"Mitchell","year":"2012","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.schres.2019.10.062_bib39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders\u2014a systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2019.10.062_bib40","first-page":"1","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Clin. Trials"},{"key":"10.1016\/j.schres.2019.10.062_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.schres.2015.03.034","article-title":"Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders","volume":"165","author":"Mothi","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.10.062_bib42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.schres.2010.09.006","article-title":"Deviant intrauterine growth and risk of schizophrenia: a 34-year follow-up of the Northern Finland 1966 Birth Cohort","volume":"124","author":"Moilanen","year":"2010","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.schres.2019.10.062_bib43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jcjd.2014.01.014","article-title":"A\u00a0meta-analysis of cognitive functioning in nondemented adults with type 2 diabetes mellitus","volume":"38","author":"Monette","year":"2014","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.schres.2019.10.062_bib44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0140-6736(89)91392-5","article-title":"Family history of type 2 diabetes in schizophrenic patients","volume":"1","author":"Mukherjee","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2019.10.062_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1573399812666151022143502","article-title":"Family history of type 2 diabetes: does having a diabetic parent increase the risk?","volume":"13","author":"Papazafiropoulou","year":"2017","journal-title":"Curr. Diabetes Rev."},{"issue":"3","key":"10.1016\/j.schres.2019.10.062_bib46","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S2215-0366(16)30262-0","article-title":"The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis","volume":"11","author":"Perry","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2019.10.062_bib68","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1176\/appi.ajp.160.4.677","article-title":"Polymorphisms of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain","volume":"160","author":"Reynolds","year":"2013","journal-title":"Am. J. Psychiatry."},{"key":"10.1016\/j.schres.2019.10.062_bib49","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ajmg.b.31057","article-title":"Functional variants of TSPAN8 are associated with bipolar disorder and schizophrenia","volume":"153B","author":"Scholz","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.schres.2019.10.062_bib63","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/016327870102400203","article-title":"Methods for exploring heterogeneity in meta-analysis","volume":"24","author":"Song","year":"2001","journal-title":"Eval. Health Prof."},{"key":"10.1016\/j.schres.2019.10.062_bib50","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1464-5491.2007.02092.x","article-title":"Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia","volume":"24","author":"Spelman","year":"2007","journal-title":"Diabet. Med."},{"key":"10.1016\/j.schres.2019.10.062_bib66","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"J.\u00a0Clin. Epidemiol."},{"key":"10.1016\/j.schres.2019.10.062_bib51","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/oxfordjournals.schbul.a007013","article-title":"Nutritional assessment of patients with schizophrenia: a preliminary study","volume":"29","author":"Strassnig","year":"2003","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2019.10.062_bib52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archpsyc.1996.01830010027005","article-title":"Schizophrenia after prenatal famine. Further evidence","volume":"53","author":"Susser","year":"1996","journal-title":"Arch. Gen. Psychiatr."},{"issue":"2\u20133","key":"10.1016\/j.schres.2019.10.062_bib53","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.schres.2012.11.011","article-title":"The prevalence of diabetes mellitus is increased in relatives of patients with a non-affective psychotic disorder","volume":"143","author":"Van Welie","year":"2013","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.10.062_bib54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.schres.2007.07.016","article-title":"Dysglycemia in a community sample of people treated for schizophrenia: the diabetes in schizophrenia in central- south ontario (DiSCO) study","volume":"96","author":"Voruganti","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.10.062_bib55","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2215-0366(15)00007-3","article-title":"The epidemiology of diabetes in psychotic disorders","volume":"2","author":"Ward","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2019.10.062_bib56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.schres.2010.02.1031","article-title":"Convergent evidence shows a positive association of interleukin-1 gene complex locus with susceptibility to schizophrenia in the caucasian population","volume":"120","author":"Xu","year":"2010","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2019.10.062_bib57","first-page":"543","article-title":"Weight gain in patients with schizophrenia and schizoaffective disorder under antipsychotic treatment: a three-year naturalistic follow-up study","volume":"18","author":"Yildiz","year":"2008","journal-title":"Bull. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2019.10.062_bib69","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbrc.2010.01.108","article-title":"Effects of atypical antipsychotic drugs on body weight and food intake in dopamine D2 receptor knockout mice","volume":"393","author":"Yoon","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.schres.2019.10.062_bib70","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/JCP.0b013e318283925e","article-title":"CNR1 gene and risk of the metabolic syndrome in patients with schizophrenia","volume":"33","author":"Yu","year":"2013","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.schres.2019.10.062_bib58","first-page":"111","article-title":"The effect of the family history of diabetes on glucose metabolism of the patients receiving atypical antipsychotics","volume":"17","author":"Yurtsever","year":"2007","journal-title":"Bull. Clin. Psychopharmacol."},{"issue":"26","key":"10.1016\/j.schres.2019.10.062_bib59","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/hup.1220","article-title":"The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine","volume":"2011","author":"Zhang","year":"2011","journal-title":"Psychopharmacol Clin. Exp."},{"key":"10.1016\/j.schres.2019.10.062_bib60","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.4088\/JCP.12m07846","article-title":"The DM2 mellitus susceptibility gene IGF2BP2 is associated with schizophrenia in a Han Chinese population","volume":"74","author":"Zhang","year":"2013","journal-title":"J.\u00a0Clin. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419304979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419304979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:33:27Z","timestamp":1760297607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996419304979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":67,"alternative-id":["S0920996419304979"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2019.10.062","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis of comorbid diabetes and family history of diabetes in non-affective psychosis","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2019.10.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}